Paul Ehrlich's magic bullet concept: 100 years of progress
@article{Strebhardt2008PaulEM, title={Paul Ehrlich's magic bullet concept: 100 years of progress}, author={K. Strebhardt and A. Ullrich}, journal={Nature Reviews Cancer}, year={2008}, volume={8}, pages={473-480} }
Exceptional advances in molecular biology and genetic research have expedited cancer drug development tremendously. The declared paradigm is the development of 'personalized and tailored drugs' that precisely target the specific molecular defects of a cancer patient. It is therefore appropriate to revisit the intellectual foundations of the development of such agents, as many have shown great clinical success. One hundred years ago, Paul Ehrlich, the founder of chemotherapy, received the Nobel… CONTINUE READING
Figures and Topics from this paper
Figures
785 Citations
The impact of molecular targets in cancer drug development: major hurdles and future strategies
- Medicine
- Expert review of clinical pharmacology
- 2013
- 16
Combination cancer immunotherapy "Expanding Paul Ehrlich's Magic Bullet Concept".
- Medicine
- Surgical oncology
- 2012
- 11
- PDF
Tailoring the Treatment of Melanoma: Implications for Personalized Medicine
- Medicine
- The Yale journal of biology and medicine
- 2015
- 3
Cancer immunotherapy: Breakthrough or “deja vu, all over again”?
- Medicine
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
- 2017
- 9
Targeting active cancer cells with smart bullets
- Computer Science, Medicine
- Therapeutic delivery
- 2017
- 10
- PDF
References
SHOWING 1-10 OF 166 REFERENCES
Model organisms: The mighty mouse: genetically engineered mouse models in cancer drug development
- Biology, Medicine
- Nature Reviews Drug Discovery
- 2006
- 342
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.
- Biology, Medicine
- Pharmacology & therapeutics
- 1991
- 300
Expanding the repertoire of RNA interference screens for developing new anticancer drug targets
- Biology, Medicine
- Expert opinion on therapeutic targets
- 2007
- 13
Strategies to overcome resistance to targeted protein kinase inhibitors
- Biology, Medicine
- Nature Reviews Drug Discovery
- 2004
- 316
- PDF